Drug Profile
Research programme: melanocortin-4 receptor agonists - Amgen
Latest Information Update: 09 Sep 2008
Price :
$50
*
At a glance
- Originator Amgen
- Class Amides; Piperazines
- Mechanism of Action Melanocortin type 4 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Obesity
Most Recent Events
- 13 Sep 2004 Preclinical trials in Obesity in USA (PO)